Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
09/09

DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ slid 2.15% to $7.73 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.45% to 21,798.70 and the Dow Jones Industrial Average rising 0.25% to 45,514.95.

The stock's fall snapped a two-day winning streak.

Novavax Inc. closed 49.21% below its 52-week high of $15.22, which the company reached on October 2nd.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.17% to $178.13, Pfizer Inc. $(PFE)$ fell 1.33% to $24.55, and Merck & Co. Inc. $(MRK)$ fell 0.73% to $84.09.

Trading volume (3.5 M) remained 3.3 million below its 50-day average volume of 6.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

September 08, 2025 17:30 ET (21:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10